The biopolymer maker reported a GAAP loss of $0.01 per share and a 9.2% year-over-year revenue decline for Q2.
EcoSynthetix reported a Q2 GAAP loss of $0.01 per share on revenue of $4.54 million, down 9.2% from the same period last year. The decline reflects ongoing challenges in scaling operations amid market conditions.
Cash reserves stood at $29.1 million as of June 30, 2026, slightly lower than the $29.6 million recorded at the end of 2025. The company also repurchased and canceled 368,095 common shares during the quarter.
No immediate market reaction was disclosed in the release.